Skip to main content
SpringerLink
Log in

Aktuelle internistische Literatur referiert und kommentiert

  • JOURNAL CLUB
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ogawa H, Nakayama M, Morimoto T, et al., for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes. JAMA 2008;300:2134–2141.

    Article  PubMed  CAS  Google Scholar 

  2. Belch J, MacCuish A, Campbel I, et al. The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. Br Med J 2008;337:1030–1034.

    Article  Google Scholar 

Literatur

  1. Razvi S, Shakoor A, Vanderpump M, et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008; 93:2998–3007.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes. JAMA 2008; 300:2886–2897.

    Article  PubMed  CAS  Google Scholar 

  2. Harder T, Rodekamp E, Schellong K, et al. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 2007;165:849–857

    Article  PubMed  Google Scholar 

Literatur

  1. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–463.

    Article  PubMed  Google Scholar 

  2. Garcia-Aymerich J, Monsó E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2001;164:1002–1007.

    PubMed  CAS  Google Scholar 

  3. Gillissen A, Buhl R, Kardos P, et al. Studienendpunkte bei der chronisch-obstruktiven Lungenerkrankung (COPD): minimal clinically important difference. Pneumologie 2008;62:149–157.

    Article  PubMed  CAS  Google Scholar 

  4. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61:772–778.

    Article  PubMed  CAS  Google Scholar 

  5. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009; 33:362–372.

    Google Scholar 

  6. Pitta F, Troosteres T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–977.

    Article  PubMed  Google Scholar 

  7. Schönhofer B, Ardes P, Geibel M, et al. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814–2819.

    Article  PubMed  Google Scholar 

  8. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1423–1434.

    Article  PubMed  Google Scholar 

Literatur

  1. Singh S, Evans TW. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J 1997;10:699–707.

    PubMed  CAS  Google Scholar 

  2. De Jongste JC, Carraro S, Hop WC, et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009;179:93–97.

    Article  PubMed  Google Scholar 

  3. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143–178.

    Article  PubMed  CAS  Google Scholar 

  4. Gillissen A, Wirtz H, Hoheisel GB. Paradigmenwechsel in der Therapieempfehlung des Asthma bronchiale. Med Klin 2007;102:399–403.

    Article  Google Scholar 

  5. Stick S, Franklin P. No more dogma. Am J Respir Crit Care Med 2009;179:87–92.

    Article  PubMed  Google Scholar 

  6. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management. Am J Respir Crit Care Med 2007;176:231–237.

    Article  PubMed  CAS  Google Scholar 

  7. Smith AD, Cowan JO, Brasset KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163–2173.

    Article  PubMed  CAS  Google Scholar 

  8. Dupont LJ, Rochette F, Demedts MG, et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998;157:894–898.

    PubMed  CAS  Google Scholar 

  9. Ludviksdottir D, Janson C, Högman M, et al. Exhaled nitric oxide and its relationship to airwa responsiveness and atopy in asthma. Respir Med 1999;93:552–556.

    Article  PubMed  CAS  Google Scholar 

  10. Holz O, Buhl R, Hausen T, et al. Messung der Atemwegsentzündung in der pneumologischen Praxis — Anwendung und Interpretation. Pneumologie 2007;61:194–201.

    Article  PubMed  CAS  Google Scholar 

  11. Petsky HL, Cates CJ, Li AM, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2008;2:CD006340.

    Google Scholar 

Literatur

  1. Lernout T, Kissling E, Hutse V, et al. An outbreak of measles in orthodox Jewish communities in Antwerp, Belgium, 2007-2008: different reasons for accumlation of susceptibles. Eur Surveill 2009;14: pii:19087.

    Google Scholar 

  2. Center of Disease Control. Progress toward measles elimination — Japan, 1999–2008. MMWR Morb Mortal Wkly Rep 2008;57:1049–1052.

    Google Scholar 

  3. Hamlin J, Senthilnathan S, Bernstein HH. Update on universal childhood immunizations. Curr Opin Pediatr 2008;20:483–489.

    Article  PubMed  Google Scholar 

  4. Muscat M, Bang H, Wohlfahrt J, et al. Measles in Europe: an epidemiological assessment. Lancet 2009; 373:383–389.

    Article  PubMed  Google Scholar 

  5. World Health Organization. Strategies for reducing global measles mortality. Wkly Epidemiol Rec 2000;75:411–416.

    Google Scholar 

  6. Center of Disease Control. Progress in global measles control and mortality reduction, 2000–2007. MMWR Morb Mortal Wkly Rep 2008;57: 1303–1306.

    Google Scholar 

  7. Strebel P, Cochi S, Grabowsky M, et al. The unfinished measles immunization agenda. J Infect Dis 2003;187:Suppl 1:S1–7.

    Article  PubMed  Google Scholar 

  8. Wichmann O, Siedler A, Sagebiel D, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ 2009;87:108–115.

    Article  PubMed  Google Scholar 

Literatur

  1. Hershfield MS, Arredondo-Vega FX, Santisteban I. Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency. J Inherit Metab Dis 1997;20:179–185.

    Article  PubMed  CAS  Google Scholar 

  2. Blaese RM, Culver K, Miller AD, et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995;270: 475–480.

    Article  PubMed  CAS  Google Scholar 

  3. Hirschhorn R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr Res 1993;33:Suppl: S35–S41.

    Article  PubMed  CAS  Google Scholar 

  4. Anderson WF, Blaese RM, Culver K. The ADA human gene therapy clinical protocol: points to consider response with clinical protocol, July 6, 1990. Hum Gene Ther 1990;1:331–362.

    Article  PubMed  Google Scholar 

  5. Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009;360: 447–458.

    Article  PubMed  CAS  Google Scholar 

  6. Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003;361:553–560.

    Article  PubMed  Google Scholar 

Literatur

  1. Tonino PAL, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention (FAME study). N Engl J Med 2009;360:213–224.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aktuelle internistische Literatur referiert und kommentiert. Med Klin 104, 251–263 (2009). https://doi.org/10.1007/s00063-009-1040-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1040-8

Search

Navigation